Oligoclonal Band Status in Scandinavian Multiple Sclerosis Patients Is Associated with Specific Genetic Risk Alleles

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Mero, Inger Lise ^a,b   Gustavsen, Marte W ^a,d   Sæther, Hanne S ^a,b   Flåm, Siri T ^b   Berg Hansen, Pål ^a,d   Søndergaard, Helle B ^c   Jensen, Poul Erik H ^c   Berge, Tone ^a,d   Bjølgerud, Anja ^a,d   Muggerud, Aslaug ^a,d   Aarseth, Jan H ^e   Myhr, Kjell Morten ^e,f   Celius, Elisabeth G ^a   Sellebjerg, Finn ^c   Hillert, Jan ^g   Alfredsson, Lars ^g   Olsson, Tomas ^g   Oturai, Annette Bang ^c   Kockum, Ingrid ^g   Lie, Benedicte A ^b   Andreassen, Bettina Kulle ^d   Harbo, Hanne F ^a,d   more..

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c Rigshospitalet   (Denmark)

^d UNIVERSITY OF OSLO   (Norway)

^e HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^f UNIVERSITY OF BERGEN   (Norway)

^g KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CALSYNTENIN 2; HLA DRB1 ANTIGEN; OLIGOCLONAL BAND; SYNTENIN; UNCLASSIFIED DRUG;

ALLELE; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GENE; GENE ACTIVITY; GENE FUNCTION; GENE LOCUS; GENE REPLICATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC DIFFERENCE; GENETIC RISK; GENOTYPE; HLA DRB1 GENE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; RISK ASSESSMENT; RISK REDUCTION; SCANDINAVIA; SINGLE NUCLEOTIDE POLYMORPHISM; ADULT; CASE CONTROL STUDY; CEREBROSPINAL FLUID; DENMARK; GENE FREQUENCY; GENETICS; NORWAY; SWEDEN;

ADULT; ALLELES; CASE-CONTROL STUDIES; DENMARK; FEMALE; GENE FREQUENCY; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HLA-DRB1 CHAINS; HUMANS; MALE; MULTIPLE SCLEROSIS; NORWAY; OLIGOCLONAL BANDS; POLYMORPHISM, SINGLE NUCLEOTIDE; SWEDEN;

EID: 84874604770     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0058352     Document Type: Article

References (42)

1. Compston A, Coles A, (2008) Multiple sclerosis. Lancet 372: 1502-1517.
2. Jersild C, Svejgaard A, Fog T, (1972) HL-A antigens and multiple sclerosis. Lancet 1: 1240-1241.
3. The International Multiple Sclerosis Consortium (IMSGC) and Wellcome Trust Case Control Consortium 2 (WTCCC2) (2011) Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature 476: 214-219.
4. The International Multiple Sclerosis Genetics Consortium (IMSGC) (2007) Risk alleles for multiple sclerosis identified by a genomewide study. N Engl J Med 357: 851-862.
5. Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, et al. (1983) New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 13: 227-231.
6. McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, et al. (2001) Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 50: 121-127.
7. Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, et al. (2011) Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria. Ann Neurol 69: 292-302.
8. Link H, Huang YM, (2006) Oligoclonal bands in multiple sclerosis cerebrospinal fluid: an update on methodology and clinical usefulness. J Neuroimmunol 180: 17-28.
9. Andersson M, Alvarez-Cermeno J, Bernardi G, Cogato I, Fredman P, et al. (1994) Cerebrospinal fluid in the diagnosis of multiple sclerosis: a consensus report. J Neurol Neurosurg Psychiatry 57: 897-902.
10. Lechner-Scott J, Spencer B, de MT, Attia J, Fitzgerald M et al. (2011) The frequency of CSF oligoclonal banding in multiple sclerosis increases with latitude. Mult Scler.
11. Balnyte R, Rastenyte D, Uloziene I, Mickeviciene D, Skordeniene E, et al. (2011) The Significance of HLA DRB1*1501 and Oligoclonal Bands in Multiple Sclerosis: Clinical Features and Disability. Medicina (Kaunas) 47: 368-373.
12. Imrell K, Landtblom AM, Hillert J, Masterman T, (2006) Multiple sclerosis with and without CSF bands: clinically indistinguishable but immunogenetically distinct. Neurology 67: 1062-1064.
13. Imrell K, Greiner E, Hillert J, Masterman T, (2009) HLA-DRB115 and cerebrospinal-fluid-specific oligoclonal immunoglobulin G bands lower age at attainment of important disease milestones in multiple sclerosis. J Neuroimmunol 210: 128-130.
14. Idiman E, Ozakbas S, Dogan Y, Kosehasanogullari G, (2009) The significance of oligoclonal bands in multiple sclerosis: relevance of demographic and clinical features, and immunogenetic backgrounds. J Neuroimmunol 212: 121-124.
15. Joseph FG, Hirst CL, Pickersgill TP, Ben-Shlomo Y, Robertson NP, et al. (2009) CSF oligoclonal band status informs prognosis in multiple sclerosis: a case control study of 100 patients. J Neurol Neurosurg Psychiatry 80: 292-296.
16. Siritho S, Freedman MS, (2009) The prognostic significance of cerebrospinal fluid in multiple sclerosis. J Neurol Sci 279: 21-25.
17. Wu JS, Qiu W, Castley A, James I, Joseph J, et al. (2010) Presence of CSF oligoclonal bands (OCB) is associated with the HLA-DRB1 genotype in a West Australian multiple sclerosis cohort. J Neurol Sci 288: 63-67.
18. Romero-Pinel L, Martinez-Yelamos S, Bau L, Matas E, Gubieras L, et al. (2011) Association of HLA-DRB1*15 allele and CSF oligoclonal bands in a Spanish multiple sclerosis cohort. Eur J Neurol 18: 1258-1262.
19. Kikuchi S, Fukazawa T, Niino M, Yabe I, Miyagishi R, et al. (2003) HLA-related subpopulations of MS in Japanese with and without oligoclonal IgG bands. Human leukocyte antigen. Neurology 60: 647-651.
20. Hedstrom AK, Baarnhielm M, Olsson T, Alfredsson L, (2009) Tobacco smoking, but not Swedish snuff use, increases the risk of multiple sclerosis. Neurology 73: 696-701.
21. Fujita PA, Rhead B, Zweig AS, Hinrichs AS, Karolchik D, et al. (2011) The UCSC Genome Browser database: update 2011. Nucleic Acids Res 39: D876-D882.
22. Harbo HF, Lie BA, Sawcer S, Celius EG, Dai KZ, et al. (2004) Genes in the HLA class I region may contribute to the HLA class II-associated genetic susceptibility to multiple sclerosis. Tissue Antigens 63: 237-247.
23. Lorentzen AR, Karlsen TH, Olsson M, Smestad C, Mero IL, et al. (2009) Killer immunoglobulin-like receptor ligand HLA-Bw4 protects against multiple sclerosis. Ann Neurol 65: 658-666.
24. Sayer DC, Whidborne R, De SD, Rozemuller EH, Christiansen FT, et al. (2004) A multicenter international evaluation of single-tube amplification protocols for sequencing-based typing of HLA-DRB1 and HLA-DRB3,4,5. Tissue Antigens 63: 412-423.
25. Link J, Lorentzen AR, Kockum I, Duvefelt K, Lie BA, et al. (2010) Two HLA class I genes independently associated with multiple sclerosis. J Neuroimmunol 226: 172-176.
26. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, et al. (2007) PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81: 559-575.
27. Dudbridge F, (2008) Likelihood-based association analysis for nuclear families and unrelated subjects with missing genotype data. Hum Hered 66: 87-98.
28. Zhang Q, Lin CY, Dong Q, Wang J, Wang W, (2011) Relationship between HLA-DRB1 polymorphism and susceptibility or resistance to multiple sclerosis in Caucasians: a meta-analysis of non-family-based studies. Autoimmun Rev 10: 474-481.
29. Dyment DA, Herrera BM, Cader MZ, Willer CJ, Lincoln MR, et al. (2005) Complex interactions among MHC haplotypes in multiple sclerosis: susceptibility and resistance. Hum Mol Genet 14: 2019-2026.
30. Barcellos LF, Sawcer S, Ramsay PP, Baranzini SE, Thomson G, et al. (2006) Heterogeneity at the HLA-DRB1 locus and risk for multiple sclerosis. Hum Mol Genet 15: 2813-2824.
31. Liu F, Arias-Vasquez A, Sleegers K, Aulchenko YS, Kayser M, et al. (2007) A genomewide screen for late-onset Alzheimer disease in a genetically isolated Dutch population. Am J Hum Genet 81: 17-31.
32. Papassotiropoulos A, Stephan DA, Huentelman MJ, Hoerndli FJ, Craig DW, et al. (2006) Common Kibra alleles are associated with human memory performance. Science 314: 475-478.
33. Sedille-Mostafaie N, Sebesta C, Huber KR, Zehetmayer S, Jungwirth S, et al. (2012) The role of memory-related gene polymorphisms, KIBRA and CLSTN2, on replicate memory assessment in the elderly. J Neural Transm 119: 77-80.
34. Hintsch G, Zurlinden A, Meskenaite V, Steuble M, Fink-Widmer K, et al. (2002) The calsyntenins-a family of postsynaptic membrane proteins with distinct neuronal expression patterns. Mol Cell Neurosci 21: 393-409.
35. Buck D, Albrecht E, Aslam M, Goris A, Hauenstein N et al. (2012) Genetic variants in the immunoglobulin heavy chain locus are associated with the IgG index in multiple sclerosis. Ann Neurol.
36. Tintore M, Sastre-Garriga J, (2009) Role of MRI criteria and OB for diagnosing multiple sclerosis in patients presenting with clinically isolated syndromes. Mult Scler 15: 407-408.
37. Lourenco P, Shirani A, Saeedi J, Oger J, Schreiber WE et al. (2012) Oligoclonal bands and cerebrospinal fluid markers in multiple sclerosis: associations with disease course and progression. Mult Scler.
38. Annunziata P, Giorgio A, De SL, Zipoli V, Portaccio E, et al. (2006) Absence of cerebrospinal fluid oligoclonal bands is associated with delayed disability progression in relapsing-remitting MS patients treated with interferon-beta. J Neurol Sci 244: 97-102.
39. Lundkvist M, Greiner E, Hillert J, Fogdell-Hahn A, (2010) Multiple sclerosis patients lacking oligoclonal bands in the cerebrospinal fluid are less likely to develop neutralizing antibodies against interferon beta. Mult Scler 16: 796-800.
40. Ballerini C, Guerini FR, Rombola G, Rosati E, Massacesi L, et al. (2004) HLA-multiple sclerosis association in continental Italy and correlation with disease prevalence in Europe. J Neuroimmunol 150: 178-185.
41. Marrosu MG, Murru R, Murru MR, Costa G, Zavattari P, et al. (2001) Dissection of the HLA association with multiple sclerosis in the founder isolated population of Sardinia. Hum Mol Genet 10: 2907-2916.
42. Saruhan-Direskeneli G, Esin S, Baykan-Kurt B, Ornek I, Vaughan R, et al. (1997) HLA-DR and-DQ associations with multiple sclerosis in Turkey. Hum Immunol 55: 59-65.